For which lung cancer patients is re-administration of immune checkpoint inhibitors effective? | J Rural Med;16(4): 256-262, 2021 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

For which lung cancer patients is re-administration of immune checkpoint inhibitors effective?

Sasaki, Takanobu; Tabata, Toshiharu; Yoshimura, Naruo.

Affiliation

Sasaki T; Department of Thoracic Surgery, Tohoku Medical and Pharmaceutical University, Japan.
Tabata T; Department of Public Health, Graduate School of Medicine, Tohoku University, Japan.
Yoshimura N; Department of Thoracic Surgery, Tohoku Medical and Pharmaceutical University, Japan.

J Rural Med ; 16(4): 256-262, 2021 Oct.

Article in En | MEDLINE | ID: mdl-34707736

Key words

Key wordslung cancer; immune checkpoint inhibitors; re-administration

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Rural Med Year: 2021 Document type: Article Affiliation country: Japan Country of publication: Japan

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Rural Med Year: 2021 Document type: Article Affiliation country: Japan Country of publication: Japan